[go: up one dir, main page]

PE110098A1 - Derivados de 1-carba-(detia)-cefalosporina - Google Patents

Derivados de 1-carba-(detia)-cefalosporina

Info

Publication number
PE110098A1
PE110098A1 PE1997000839A PE00083997A PE110098A1 PE 110098 A1 PE110098 A1 PE 110098A1 PE 1997000839 A PE1997000839 A PE 1997000839A PE 00083997 A PE00083997 A PE 00083997A PE 110098 A1 PE110098 A1 PE 110098A1
Authority
PE
Peru
Prior art keywords
formula
compounds
piridinio
detia
carba
Prior art date
Application number
PE1997000839A
Other languages
English (en)
Inventor
Paul Hebeisen
Ingrid Heinze-Krauss
Malcolm Page
Peter Angehrn
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of PE110098A1 publication Critical patent/PE110098A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D463/00—Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D463/10—Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D463/14—Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hetero atoms directly attached in position 7
    • C07D463/16—Nitrogen atoms
    • C07D463/18—Nitrogen atoms further acylated by radicals derived from carboxylic acids or by nitrogen or sulfur analogues thereof
    • C07D463/20—Nitrogen atoms further acylated by radicals derived from carboxylic acids or by nitrogen or sulfur analogues thereof with the acylating radicals further substituted by hetero atoms or by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D463/22—Nitrogen atoms further acylated by radicals derived from carboxylic acids or by nitrogen or sulfur analogues thereof with the acylating radicals further substituted by hetero atoms or by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen further substituted by nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

SE REFIEREN A COMPUESTOS DE FORMULA (I), EN DONDE: "X" ES CH o N; R1 ES H, ALQUILO INFERIOR OPCIONALMENTE SUSTITUIDO CON F, CICLOALQUILO, ENTRE OTROS; R2 ES H, OH, ENTRE OTROS, R2 DE PREFERENCIA ES PIRIDINA, METILPIRIDINA, 1-(N-FENIL-CARBAMOIL-METIL)-PIRIDINIO o 1-[N-(3-FLUORO-4-HIDROXIFENIL)CARBAMOILMETIL]PIRIDINIO; R3 ES OH, -O-, ALCOXILO INFERIOR o OM, EN DONDE: "M" ES UN METAL ALCALINO; n ES 0; 1 o 2. TAMBIEN SE REFIERE AL PROCEDIMIENTO DE PREPARACION DE LOS COMPUESTOS DE FORMULA (I) Y AL COMPUESTO INTERMEDIO DE FORMULA (II) PARA SU OBTENCION. LOS COMPUESTOS DE FORMULA (I) PRESENTAN UNA ACTIVIDAD ANTIBACTERIANA POTENTE Y AMPLIA, ESPECIALMENTE CONTRA LOS ESTAFILOCOCOS RESISTENTES A LA METICILINA (MRSA) Y LA PSEUDOMONA AERUGINOSA
PE1997000839A 1996-09-23 1997-09-19 Derivados de 1-carba-(detia)-cefalosporina PE110098A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP96115210 1996-09-23

Publications (1)

Publication Number Publication Date
PE110098A1 true PE110098A1 (es) 1999-01-13

Family

ID=8223209

Family Applications (1)

Application Number Title Priority Date Filing Date
PE1997000839A PE110098A1 (es) 1996-09-23 1997-09-19 Derivados de 1-carba-(detia)-cefalosporina

Country Status (23)

Country Link
US (1) US5939410A (es)
JP (1) JPH10101670A (es)
KR (1) KR100256473B1 (es)
CN (1) CN1184110A (es)
AR (1) AR008450A1 (es)
AU (1) AU723176B2 (es)
BR (1) BR9704770A (es)
CA (1) CA2216222A1 (es)
CO (1) CO4900072A1 (es)
CZ (1) CZ292097A3 (es)
HR (1) HRP970511A2 (es)
HU (1) HUP9701548A3 (es)
ID (1) ID18323A (es)
IL (1) IL121798A0 (es)
MA (1) MA26442A1 (es)
NO (1) NO974366L (es)
NZ (1) NZ328595A (es)
PE (1) PE110098A1 (es)
PL (1) PL322240A1 (es)
SG (1) SG53049A1 (es)
TR (1) TR199701011A2 (es)
YU (1) YU38497A (es)
ZA (1) ZA978332B (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EA201070504A1 (ru) * 2007-10-25 2010-12-30 Эйкеоджен, Инк. КАРБАЦЕФЕМ β-ЛАКТАМОВЫЕ АНТИБИОТИКИ
WO2010030810A1 (en) * 2008-09-10 2010-03-18 Achaogen, Inc. Carbacephem beta-lactam antibiotics

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0112481A1 (en) * 1982-11-12 1984-07-04 Kyowa Hakko Kogyo Co., Ltd Beta-lactam compound
GB9213567D0 (en) * 1992-06-26 1992-08-12 Smithkline Beecham Plc Novel compounds
ATE227728T1 (de) * 1993-04-16 2002-11-15 Basilea Pharmaceutica Ag Cephalosporin-derivate
JPH11501017A (ja) * 1995-02-27 1999-01-26 エフ・ホフマン−ラ ロシュ アーゲー ３−ピロリジリデン−２−オン−セファロスポリンの誘導体
EP0761673A1 (en) * 1995-09-12 1997-03-12 F. Hoffmann-La Roche Ag Cephalosporin derivatives

Also Published As

Publication number Publication date
AU3838297A (en) 1998-01-15
YU38497A (sh) 1999-12-27
MX9707201A (es) 1998-06-28
AU723176B2 (en) 2000-08-17
HUP9701548A2 (hu) 1999-05-28
ZA978332B (en) 1998-03-23
US5939410A (en) 1999-08-17
NZ328595A (en) 1999-01-28
TR199701011A2 (xx) 1998-04-21
SG53049A1 (en) 1998-09-28
IL121798A0 (en) 1998-02-22
MA26442A1 (fr) 2004-12-20
CO4900072A1 (es) 2000-03-27
CN1184110A (zh) 1998-06-10
ID18323A (id) 1998-03-26
HUP9701548A3 (en) 2001-04-28
BR9704770A (pt) 1998-11-03
PL322240A1 (en) 1998-03-30
NO974366D0 (no) 1997-09-22
CA2216222A1 (en) 1998-03-23
JPH10101670A (ja) 1998-04-21
KR100256473B1 (ko) 2000-05-15
NO974366L (no) 1998-03-24
CZ292097A3 (cs) 1998-04-15
KR19980024863A (ko) 1998-07-06
AR008450A1 (es) 2000-01-19
HRP970511A2 (en) 1998-08-31
HU9701548D0 (en) 1997-11-28

Similar Documents

Publication Publication Date Title
DK1221440T3 (da) Benzoheterocykliske derivater der er nyttige som vasopressin- eller oxytocinmodulatorer
ES8701173A1 (es) Procedimiento para la fabricacion de derivados de pirazol tienil condensados
HU911001D0 (en) 3,5-di-tertian-buthyl-4-hydroxy-phenyl-methylene derivatives of 2-substituted tiazolidinones and imidazolidinones as antiflammable active agents
AU583651B2 (en) Novel nitromethylene derivatives
CA2396738A1 (en) Thiazole derivatives as active superoxide radical inhibitors
DE60129712D1 (de) Oxazolylaryloxyessigsäure derivate und ihre verwendung als ppar agonisten
DK0595610T3 (da) Benzokondenserede lactamer
IL134905A0 (en) Novel intermediates for endothelin antagonistic pyrrolidine derivatives
TR200800474T2 (tr) Florfenikole aracı maddelerin hazırlanmasına ilişkin işlem.
ES2132415T3 (es) Nuevos derivados de 5-pirrolil-2-piridilmetilsulfinilbencimidazol.
DK51087A (da) Antihypercholesterolaemiske forbindelser
ES2182349T3 (es) Procedimiento de orto-metalizacion para la sintesis de 1-(tetrazol-5-il)bencenos sustituidos en la posicion 2.
PE34996A1 (es) Nuevo derivado de pirrocarbazol
DE69300169D1 (de) Substituierte Pyrrolidinderivate als HIV-Protease-Hemmer.
ES2138623T3 (es) Derivados de pleuromutilina.
PE110098A1 (es) Derivados de 1-carba-(detia)-cefalosporina
AUPN952696A0 (en) New heterocyclic compounds
FI933755A (fi) Foerfarande foer framstaellning av trans-piperidin-2,5-dikarboxylater
DE69906243T2 (de) 2-Indanmethanolderivate und ihre Verwendung als Riechstoffe
CA2349452A1 (en) Therapeutic agents for drug dependence
DE69533573D1 (de) Anxiolytischer wirkstoff
YU43499A (sh) Kristalna hidratovana natrijumova so (e)-4,6-dihloro-3- (2-okso-1-fenilpirolidin-3-iliden metil)-1h-indol-2- karboksilne kiseline
ATE181327T1 (de) Indolderivate
DE69320420D1 (de) Benzyl- und Benzhydryl Alkohole
FI953994A (fi) Menetelmä (-)-N-metyyli-N-(4-(4-fenyyli-4-asetyyliaminopiperidiini-1-yl)-2-(3,4-diklorofenyyli)butyyli)bentsamidi ja sen farmaseuttisesti hyväksyttäviä suoloja

Legal Events

Date Code Title Description
FG Grant, registration
FD Application declared void or lapsed